Increase in BODY WEIGHT over existing weight.
| Excerpt | Reference |
|---|
| "Weight gain is a common side effect during oral contraceptive use." | ( Karlsson, R; Lindén, A; von Schoultz, B, 1992) |
| "Weight gain is thus a common occurrence for women at the time of menopause and is related to the changes in coronary heart disease risk factors observed during this period." | ( Kuller, LH; Matthews, KA; Meilahn, EN; Plantinga, PL; Wing, RR, 1991) |
| "Undesired weight gain is a common complaint of patients receiving pharmacological treatment for major affective disorders." | ( Garland, EJ; Remick, RA; Zis, AP, 1988) |
| "Weight gain is an undesirable side-effect of long-term lithium administration which notably interferes with treatment compliance." | ( Alastre, T; Baptista, T; Burguera, JL; Contreras, Q; de Baptista, E; de Burguera, M; Hernàndez, L; Teneud, L; Weiss, S, 1995) |
| "Posttransplant weight gain is related mainly to demographic factors, not to treatment factors associated with the transplant." | ( Adams, MB; Gallagher-Lepak, S; Johnson, CP; Kelber, S; Porth, C; Roza, AM; Zhu, YR, 1993) |
| "Weight gain is an important side effect of clozapine and is unrelated to the drug's differential antipsychotic efficacy." | ( Breier, A; Buchanan, RW; Bustillo, JR; Irish, D, 1996) |
| "Unfortunately, the weight gain is due predominantly to an increase in fat mass." | ( Knopf, K; Von Roenn, JH, 1996) |
| "Weight gain is a major side-effect of treatment with clozapine." | ( Bender, M; Blum, WF; Brömel, T; Fleischhaker, C; Hebebrand, J; Krieg, JC; Remschmidt, H; Schulz, E; Ziegler, A, 1998) |
| "Weight gain is a serious side effect of antipsychotic therapy." | ( Conley, RR; Horn, DS; Kelly, DL; Love, RC; Ushchak, CM, 1998) |
| "Therefore, body weight gain is an important issue in the management of pregnancy in women with diabetes." | ( Iwamoto, Y; Iwasaki, N; Kanamori, M; Minei, S; Omori, Y; Sanaka, M; Yanagisawa, K, 1999) |
| "To prove whether weight gain is a relevant side effect of atypical neuroleptics, the charts of all patients admitted with DSM-III-R diagnoses of schizophrenia, schizoaffective disorder, or delusional disorder in the years 1991 to 1995 were evaluated." | ( Müssigbrodt, HE; Wetterling, T, 1999) |
| "Weight gain is a frequent consequence of smoking cessation." | ( Carlson, MG; Goffaux, J; Oeser, A; Snead, W, 1999) |
| "Weight gain is associated with the use of many psychotropic medications, including lithium, valproic acid, and several conventional and newer antipsychotics." | ( Guille, C; Sachs, GS, 1999) |
| "Weight gain is a reported problem associated with adjuvant chemotherapy for breast cancer and often generates psychosocial stress in women [1]." | ( Allen, BJ; Aslani, A; Levi, JA; Pavlakis, N; Smith, RC, 1999) |
| "Fear of weight gain is one of the main factors contributing to the poor compliance seen with hormone replacement therapy (HRT)." | ( van Seumeren, I, 2000) |
| "Weight gain is a common side effect of valproate treatment." | ( Aysun, S; Demir, E, 2000) |
| "Weight gain is an important risk factor for the development of the metabolic syndrome, and inflammatory mediators are strongly associated with this syndrome." | ( Carpenter, M; Chambless, LE; Duncan, BB; Folsom, AR; Heiss, G; Schmidt, MI, 2000) |
| "Weight gain is cited as a common side effect and major reason for discontinuation of DMPA." | ( Espey, E; Ogburn, T; Qualls, C; Steinhart, J, 2000) |
| "Significant weight gain is reported with the existing atypical antipsychotics." | ( Kennedy, SH; McCann, SM; McIntyre, RS, 2001) |
| "Weight gain is modulated by sex hormones in male and female rats, with both estrogen and tamoxifen exerting immediate effects in females, irrespective of the age at which treatment is initiated." | ( Belanger, MP; Wallen, WJ; Wittnich, C, 2001) |
| "Weight gain is reported as a common finding in patients treated for breast cancer but its aetiology appears to be complex." | ( Lankester, KJ; Lawton, PA; Phillips, JE, 2002) |
| "Weight gain is a common side effect of clozapine treatment and may expose patients to obesity-associated health risks." | ( Borovicka, MC; Fuller, MA; Jaskiw, GE; Konicki, PE; Steele, VM; White, JC, 2002) |
| "Olanzapine-induced weight gain is associated with a general increase in caloric intake." | ( Apter, A; Constantini, N; Falk, B; Frishman, S; Gothelf, D; Kairi, M; Phillip, M; Poraz, I; Singer, P; Weizman, A; Zalsman, G; Zigel, L, 2002) |
| "Weight gain is a commonly encountered problem associated with antipsychotic treatment." | ( Sanders, TA; Taylor, D; Werneke, U, 2002) |
| "Weight gain is one side effect of many antipsychotic drugs (APDs)." | ( Bubser, M; Deutch, AY; Fadel, J, 2002) |
| "Weight gain is a common side effect observed in women undergoing adjuvant chemotherapy for breast cancer." | ( Banzi, MC; Bertolini, M; Bondi, M; Del Rio, G; Federico, M; Menozzi, R; Piccinini, L; Valeriani, L; Zironi, S, 2002) |
| "Weight gain is a widely reported side effect of clozapine, but no predictive factor has been identified so far." | ( Fabrazzo, M; La Pia, S; Maj, M; Monteleone, P; Tortorella, A, 2002) |
| "2." | ( Fujiwara, K; Itoh, M; Kaneko, YS; Mori, K; Nagasaka, A; Nakashima, A; Ota, A; Ota, M, 2002) |
| "Weight gain is a frequent adverse effect associated with lithium use." | ( Atmaca, M; Kuloglu, M; Tezcan, E; Ustundag, B, 2002) |
| "Weight gain is a common and potentially serious complication of some antipsychotic drug therapy, and may be accompanied by hyperlipidemia, hypertension and hyperglycemia and, in some extreme cases, diabetic ketoacidosis." | ( Ernsberger, P; Hufeisen, SJ; Jayathilake, K; Kroeze, WK; Meltzer, HY; Popadak, BA; Renock, SM; Roth, BL; Steinberg, S, 2003) |
| "Significant weight gain is a side effect associated with olanzapine treatment in some patients." | ( Bogenschutz, M; Bustillo, JR; Hammond, R; Keith, S; Lauriello, J; Parker, K; Rowland, L, 2003) |
| "Weight gain is associated with treatment with olanzapine and other psychotropic agents." | ( Allison, DB; Breier, A; Cavazzoni, P; Roychowdhury, SM; Tanaka, Y, 2003) |
| "Gestational weight gain is a strong determinant of maternal and neonatal outcomes; however, the pattern and predictors of weight gain during pregnancy among HIV-positive women are unknown." | ( Antelman, G; Fawzi, WW; Msamanga, G; Peterson, KE; Spiegelman, D; Villamor, E, 2003) |
| "Weight gain is a common adverse effect associated with the use of most antipsychotic drugs." | ( Atmaca, M; Kuloglu, M; Tezcan, E; Ustundag, B, 2003) |
| "Clinically relevant weight gain is clearly associated with olanzapine, and to lesser extent, with haloperidol and risperidone." | ( Bobes, J; Fernández, I; Garcia-Garcia, M; García-Portilla, MP; Hernández, G; Rejas, J; Rico-Villademoros, F, 2003) |
| "Interdialytic weight gain is used as a surrogate for volume expansion in haemodialysis patients and as an indicator of non-compliance." | ( Chua, B; Coladonato, J; Klassen, PS; Lazarus, JM; Lowrie, EG; Owen, WF; Reddan, DN; Szczech, LA, 2003) |
| "Weight gain is an important side effect of antipsychotic (AP) treatment." | ( de Castella, AR; Fitzgerald, PB; Kulkarni, J; Morris, MJ; Scaffidi, A, 2003) |
| "AP-induced weight gain is also associated with disruption of the hypothalamic-pituitary-gonadal axis." | ( de Castella, AR; Fitzgerald, PB; Kulkarni, J; Morris, MJ; Scaffidi, A, 2003) |
| "Weight gain is a common side effect associated with antidepressant, anxiolytic, and antipsychotic drug use." | ( Beale, M; Schwartz, TL, 2003) |
| "Weight gain is problematic, but the emergence of dyskinesias may be rare." | ( Adler, LE; Farley, GK; Novins, D; Ross, RG, 2003) |
| "Prevention of weight gain is important." | ( Chue, P; Kovacs, CS, 2003) |
| "Weight gain is a common consequence of antipsychotic drug treatment and can lead to further morbidity." | ( Fang, Q; Liu, W; Reynolds, GP; Yao, ZJ; Zhang, ZJ, 2004) |
| "DMPA-associated weight gain is paralleled by increases in total body fat, while appetite decreases on DMPA." | ( Bonny, AE; Britto, MT; Huang, B; Slap, GB; Succop, P, 2004) |
| "Weight gain is frequent after smoking cessation, and may limit patient's will to quit and long-term success." | ( Alvarez, F; Botella-Carretero, JI; Cantarero, M; Escobar-Morreale, HF; García, G; Martín, I; Valero, AM; Varela, C, 2004) |
| "Weight gain is cited as a primary reason for not trying to quit smoking." | ( Fernández Pinilla, MC; Fernández-Cruz, A; Filozof, C, 2004) |
| "Weight gain is a major side effect of treatment with clozapine and other antipsychotics." | ( Brömel, T; Hebebrand, J; Heinzel-Gutenbrunner, M; Hinney, A; Krieg, JC; Martin, M; Remschmidt, H; Theisen, FM, 2004) |
| "Weight gain is a side effect of therapy with many atypical antipsychotics and may have important clinical repercussions with respect to long-term health and treatment compliance." | ( Archibald, D; Carson, WH; Gharbia, NA; Jody, D; Marcus, R; McQuade, RD; Stock, E; Vanveggel, S, 2004) |
| "Weight gain is a common adverse effect of olanzapine, a member of the atypical antipsychotic class." | ( Hester, EK; Thrower, MR, 2005) |
| "Excessive weight gain is common after liver transplantation and frequently leads to obesity." | ( Gunson, B; Johnson, J; Neuberger, J; Richards, J, 2005) |
| "Weight gain is commonly observed with olanzapine treatment and can increase the risk for obesity, cardiovascular disease, hypertension, and diabetes mellitus." | ( Borba, CP; Cather, C; Copeland, PM; Daley, TB; Evins, AE; Freudenreich, O; Goff, DC; Hayden, D; Henderson, DC; Louie, PM; Nguyen, DD, 2005) |
| "Weight gain is an important issue in the use of atypical antipsychotics, including olanzapine." | ( Ahmed, S; Kaiser, CJ; Kinon, BJ; Kollack-Walker, S; Rotelli, MD, 2005) |
| "Weight gain is a known complication of corticosteroid maintenance therapy." | ( Alexander, JW; Alloway, RR; Boardman, R; Buell, JF; Cardi, M; First, MR; Munda, R; Rogers, CC; Roy-Chaudhury, P; Succop, P; Woodle, ES, 2005) |
| "Weight gain is a serious side effect of atypical antipsychotics, especially in childhood." | ( Bobb, AJ; Clasen, LS; Gochman, PA; Gogtay, N; Greenstein, DK; Lenane, MC; Mattai, A; Nugent, T; Rapoport, JL; Sharp, WS; Sporn, AL; Stevens, H; Tossell, JW; Yanovski, JA, 2005) |
| "Interdialytic weight gain is an important prognostic factor in dialysis patients." | ( Akçay, A; Arat, Z; Elsurer, R; Haberal, M; Ozdemir, FN; Sezer, S, 2005) |
| "In adult patients weight gain is a frequent complaint of hyperprolactinaemia and it has been associated with a high prevalence of obesity." | ( Chiarelli, F; Galluzzi, F; La Cauza, F; Salti, R; Stagi, S, 2005) |
| "Substantial weight gain is common with many atypical antipsychotics." | ( Green, AI; Gu, H; Gur, RE; Kahn, RS; Lieberman, JA; McEvoy, JP; Perkins, DO; Sharma, T; Strakowski, SM; Tohen, MF; Tollefson, GD; Zipursky, RB, 2005) |
| "Drug-induced weight gain is a serious side effect of many commonly used drugs leading to noncompliance with therapy and to exacerbation of comorbid conditions related to obesity." | ( Apovian, CM; Ness-Abramof, R, 2005) |
| "Weight gain is a common side effect of valproate treatment." | ( Aydin, K; Bideci, A; Gucuyener, K; Okuyaz, C; Serdaroglu, A, 2005) |
| "Body weight gain is a worrying side effect of many new antipsychotic drugs." | ( de Beaurepaire, R; Even, PC; Goubern, M; Minet-Ringuet, J; Tomé, D, 2006) |
| "Weight gain is a known side effect of valproate (VPA) therapy, which is associated with hyperinsulinemia and polycystic ovary-like syndrome and unfavorable lipid changes in women." | ( Isojärvi, J; Knip, M; Pakarinen, A; Pylvänen, V, 2006) |
| "Weight gain is a common and severe side effect of antipsychotic drugs." | ( de Beaurepaire, R; Even, PC; Lacroix, M; Minet-Ringuet, J; Tomé, D, 2006) |
| "Although excessive weight gain is not a common problem in children with cerebral origin spasticity, increased weight-gain velocity is prevalent in children receiving ITB therapy." | ( Ayyangar, RN; Fox, MA; McCoy, AA; Schaubel, DE, 2006) |
| "Weight gain is associated with treatment with many psychotropic agents." | ( Alves, MJ; Assunção, SS; Bracco, OL; Campos, JA; de Lima, MS; Rosa, Lde C; Ruschel, SI, 2006) |
| "Weight gain is moderate as smokers quit." | ( Beamonte, A; Gargallo, P; Jiménez-Muro, A; Marqueta, A; Nerín, I, 2007) |
| "Significant weight gain is a serious side effect of many antipsychotic medications, yet successful strategies for significant weight loss are lacking." | ( Akhtar-Danesh, N; Archie, SM; Goldberg, JO; Landeen, J; McColl, L; McNiven, J, 2007) |
| "Weight gain is a common adverse effect associated with olanzapine treatment." | ( Chen, PS; Lee, IH; Lu, RB; Wang, HC; Yang, YK; Yeh, TL, 2006) |
| "Weight gain is often perceived as inevitable with insulin therapy, particularly as we strive for tight glycaemic control and are using increasingly proactive insulin titration regimes." | ( Davies, M; Hermansen, K, 2007) |
| "Since weight gain is a common and undesirable side-effect with psychiatric medications, our observation strongly suggests the need for controlled clinical trials using these agents." | ( Jacobs, L; Katzman, MA; Logan, AC; Marcus, M; Vermani, M, 2007) |
| "Weight gain is a problem commonly encountered with antipsychotic treatment and has become more apparent with increasing use of the newer atypical antipsychotics." | ( Cao, LY; Haile, CN; Kosten, TA; Kosten, TR; Shen, Y; Tan, YL; Xu, Q; Zhang, XY; Zhou, DF, 2007) |
| "Weight gain is common adverse effect associated with the use of most typical and atypical antipsychotic." | ( Pehlic, E; Rustembegovic, A; Sapcanin, A; Sofic, E; Tahirovic, I; Toromanovic, J; Wichart, I, 2007) |
| "Weight gain is a significant side effect of valproic acid, which has not been clearly identified pathogenetically." | ( Akinci, A; Gungor, S; Ozerol, IH; Tabel, Y; Yologlu, S; Yücel, G, 2007) |
| "Weight gain is a common adverse effect of many psychotropic medications including antipsychotics, antidepressants, and mood stabilizers." | ( Boggs, AA; Cates, ME; Feldman, JM; Whaley, NP; Woolley, TW, 2008) |
| "Weight gain is a risk factor for hypertension, diabetes, ischemic heart disease, respiratory illnesses, various forms of cancer, and the metabolic syndrome." | ( Melamed, Y; Tadger, S, 2008) |
| "Weight gain is a side effect of glucocorticoid (GC) use, but the natural history and health implications of changes in weight that occur during the treatment of inflammatory disease are not understood." | ( Anderson, T; Davis, JC; Fontaine, KR; Hoffman, GS; McCune, WJ; Merkel, PA; Specks, U; Spiera, R; St Clair, EW; Stone, JH; Wung, PK, 2008) |
| "Weight gain is a major side effect of antipsychotic treatment." | ( Esen-Danaci, A; Ozlen, N; Sarandöl, A; Taneli, F; Yurtsever, F, 2008) |
| "Weight gain is an adverse metabolic effect in some children with epilepsy." | ( Fida, NM; Hamed, EA; Hamed, SA, 2009) |
| "However, weight gain is a notable adverse drug reaction of this medication in a proportion of patients and a major cause of noncompliance." | ( Deshpande, SN; Lerer, B; Nimgaonkar, VL; Srivastava, V; Thelma, B, 2008) |
| "As weight gain is one of the most frequently cited reasons for not using and for discontinuing hormonal contraceptives, in an open-label, single-arm, multicentre clinical study we evaluated the effect of the ethinylestradiol/norelgestromin contraceptive patch (EVRA, Janssen-Cilag International, Belgium) on body composition using bioelectrical impedance analysis (BIA)." | ( Bruni, V; Crosignani, P; Marelli, S; Nappi, C; Piccoli, A; Ronsini, S, 2008) |
| "As body weight gain is observed in all TSH groups, a special concept for prevention and therapy of obesity (diet, daily exercise, behaviour training) should be initiated early and additionally to medication." | ( Derwahl, KM; Dietlein, M; Kahaly, G; Kobe, C; Schicha, H; Schmidt, M, 2008) |
| "Although weight gain is a well-known adverse effect of valproic acid therapy, only a few studies have addressed weight gain associated with it in children aged 2-8 years." | ( Balestri, P; Grosso, S; Mostardini, R; Piccini, B, 2009) |
| "Weight gain is a common outcome of antipsychotics therapy in schizophrenic patients." | ( Kokare, DM; Meena, H; Nakhate, KT; Subhedar, NK, 2009) |
| "Significant weight gain is associated with increased levels of insulin and leptin, suggesting a close relationship between obesity-induced hyperinsulinemia and hyperleptinemia." | ( Chiarelli, F; la Torre, R; Mohn, A; Trotta, D; Verrotti, A, 2009) |
| "Vulnerability for weight gain is an individual trait." | ( Alsiö, J; Hulting, AL; Pickering, C; Schiöth, HB, 2009) |
| "Food intake and weight gain are known to be affected by stress." | ( Argente, J; Azcoitia, I; Calmarza-Font, I; Chowen, JA; Diz-Chaves, Y; Frago, LM; García-Cáceres, C; Garcia-Segura, LM; Lagunas, N, 2010) |
| "Body weight gain is a common side effect of treatment with antipsychotics, but the mechanisms underlying this weight gain are unknown." | ( Egerod, KL; Holst, B; Husum, H; Mellerup, E; Secher, A, 2010) |
| "Weight gain is commonly reported as a side effect of hormonal contraception and can lead to method discontinuation or reluctance to initiate the method." | ( Beksinska, ME; Farley, TM; Kleinschmidt, I; Milford, C; Smit, JA, 2010) |
| "Weight gain is a common side effect of antipsychotics, contributing to poor treatment adherence, and previously linked to the -759C/T polymorphism near the serotonin receptor 2C gene." | ( Lavedan, C; Thompson, A; Volpi, S, 2010) |
| "Weight gain is a clinically important side effect of antipsychotic drug therapy." | ( Asplund, AB; Björkhem-Bergman, L; Lindh, JD, 2011) |
| "Weight gain is a frequent reason for discontinuing the contraceptive with depot-medroxyprogesterone acetate (DMPA)." | ( Baccarin, MC; Bahamondes, L; Fernandes, AM; Medeiros, T; Morais, SS; Pantoja, M, 2010) |
| "High infancy weight gain is associated with increased body mass index (BMI) and insulin resistance (IR) in later life, but the association with later body composition has not been well explored." | ( Holst, JJ; Ingstrup, HK; Larnkjaer, A; Michaelsen, KF; Mølgaard, C; Schack-Nielsen, L, 2010) |
| "Fear of weight gain is a significant obstacle to smoking cessation, preventing some smokers from attempting to quit." | ( Jatlow, P; Makuch, R; Meandzija, B; O'Malley, SS; Toll, BA; White, M; Wu, R, 2010) |
| "The risk of weight gain is an important determinant of the acceptability and tolerability of antidepressant medication." | ( Aitchison, KJ; Dernovsek, MZ; Farmer, A; Gray, JM; Hauser, J; Henigsberg, N; Kalember, P; Keers, R; Kozel, D; Larsen, ER; Maier, W; McGuffin, P; Mendlewicz, J; Mors, O; Placentino, A; Rietschel, M; Souery, D; Strohmaier, J; Szczepankiewicz, A; Uher, R; Zobel, A, 2011) |
| "Body weight gain is one of the most serious side effects associated with clinical use of antipsychotics." | ( Harada, K; Irie, M; Kayama, Y; Kondo, Y; Matsuoka, N; Mihara, T; Ni, K; Shobo, M; Yamada, H, 2011) |
| "Weight gain is a significant problem in diabetic patients in terms of worsening glycemic control, increasing diabetic and cardiovascular morbidity and mortality, and contributing to social and psychological problems." | ( Altintaş, N; Arman, Y; Bozbey, C; Cetin Ölek, A; Cevizci, E; Mert, M; Temizel, M, 2010) |
| "Weight gain is a well-known unwanted effect of valproic acid (VPA) therapy." | ( Balestri, P; Barlocco, EG; Casarosa, E; Grosso, S; Luisi, S; Matera, M; Mostardini, R; Petraglia, F, 2011) |
| "Olanzapine-induced weight gain is associated with hyperphagia, enhanced feeding efficiency and adiposity, decreased locomotor activity and altered satiety signaling." | ( Deng, C; Huang, XF; Weston-Green, K, 2011) |
| "Weight gain is one of the major adverse effects of antipsychotics." | ( Amado, JA; Arranz, MJ; Berja, A; Crespo-Facorro, B; Garcia-Unzueta, MT; Martínez García, O; Mata, I; Perez-Iglesias, R; Vazquez-Barquero, JL, 2010) |
| "Weight gain is common for people with schizophrenia and this has serious implications for a patient's health and well being." | ( Cohn, T; Faulkner, G; Mukundan, A; Remington, G, 2010) |
| "Weight gain is an important adverse effect of risperidone, but predictors of significant weight gain have yet to be identified in pediatric patients." | ( Anderson, GM; Buitelaar, JK; Franke, B; Hoekstra, PJ; Lahuis, BE; Minderaa, RB; Mulder, EJ; Mulder, H; Scahill, L; Troost, PW, 2010) |
| "Weight gain is an undesirable side effect of second-generation antipsychotics (SGAs)." | ( Arango, C; Bretón, I; Camblor, M; Cuerda, C; de Castro, MJ; Desco, M; Dulín, E; García-Peris, P; Giráldez, M; Gutierrez, A; Leiva, M; Merchan-Naranjo, J; Parellada, M; Sanz, I; Velasco, C, 2011) |
| "Weight gain is a frequently occurring serious somatic adverse effect of atypical antipsychotic agents." | ( Egberts, TC; Gregoor, JG; Heerdink, ER; Loovers, HM; van der Weide, J; van Megen, HJ, 2011) |
| "The weight gain is an important issue in patients with diabetes." | ( Migdalis, IN, 2011) |
| "Weight gain is to be encouraged." | ( Klibanski, A; Misra, M, 2011) |
| "Weight gain is commonly observed with olanzapine treatment." | ( Guerdjikova, AI; Keck, PE; Martens, B; McCoy, J; McElroy, SL; Moeller, D; Mori, N; Winstanley, E, 2012) |
| "Weight gain is a common problem of treatment with atypical antipsychotics." | ( Leucht, S; Staeker, J; Steimer, W, 2012) |
| "Olanzapine-induced weight gain is associated with reduced appetite-inhibiting POMC and increased NPY." | ( Deng, C; Huang, XF; Weston-Green, K, 2012) |
| "Weight gain is commonly reported by breast cancer patients on tamoxifen or aromatase inhibitors." | ( Cuzick, J; Dowsett, M; Forbes, JF; Harvie, M; Howell, A; Sestak, I, 2012) |
| "Weight gain is common for individuals with serious mental illness (SMI) receiving antipsychotic drug therapy." | ( Chwastiak, L; Palmese, LB; Ratliff, JC; Tek, C; Tonizzo, KM, 2012) |
| "Excess weight gain is the most significant preventable cause of increased blood pressure (BP) in patients with essential hypertension and increases the risk for cardiovascular and renal diseases." | ( da Silva, AA; do Carmo, JM; Hall, JE, 2013) |
| "Risperidone-induced weight gain is associated with hyperphagia and a reduction in locomotor activity in C57BL/6J mice." | ( Allison, DB; Johnson, MS; Kesterson, RA; Li, X; Li, Y; Nagy, TR; Smith, DL, 2013) |
| "Body weight gain is the difference between 2 BW measured 131 d apart during a period of good nutrition between prelambing and weaning." | ( Ferguson, MB; Kause, A; Mulder, HA; Rose, G; Thompson, AN; van Arendonk, JA; van der Werf, JH, 2013) |
| "Induced weight gain is a disturbing side effect of Olanzapine that affects the quality of life in psychotic patients." | ( Alizadeh, A; Asadlo, M; Ghanepour, A; Ranjbar, F; Sadeghi-Bazargani, H, 2013) |
| "Post-cessation weight gain is a commonly cited barrier to smoking cessation." | ( Allen, AM; Kleppinger, A; Lando, H; Oncken, C, 2013) |
| "Excessive weight gain is a major metabolic side effect of second-generation antipsychotics (SGAs) in the treatment of schizophrenia." | ( Deng, C; He, M; Huang, XF; Lian, J; Wang, H; Zhang, Q, 2014) |
| "Abnormal weight gain is a side effect of long-term doxycycline and hydroxychloroquine treatment." | ( Angelakis, E; Armougom, F; Giorgi, R; Kankoe, S; Lagier, JC; Million, M; Raoult, D, 2014) |
| "Weight gain is a concern with the contraceptive depot-medroxyprogesterone acetate (DMPA); however, this issue remains controversial." | ( Bahamondes, L; Bahamondes, MV; Bottura, BF; Dal'Ava, N; Monteiro, I, 2014) |
| "The rate of weight gain is also an important contributing factor." | ( Ghugre, P; Raje, L, 2012) |
| "Weight gain is very common among smear-positive tuberculosis patients after treatment even though weight gain does not correlate well with underlying disease, sputum conversion and chest X-ray changes." | ( Fauzi, AR; How, SH; Kuan, YC; Ng, TH; Razali, MR, 2014) |
| "Weight gain is the most frequent adverse effect of valproic acid (VPA) treatment, resulting in poor compliance and many endocrine disturbances." | ( Chen, X; Chen, Z; Hou, X; Huang, M; Li, H; Li, J; Ni, G; Su, Q; Wang, X; Xie, W; Xin, S; Zhou, L; Zhou, Y, 2015) |
| "Weight gain is a major side effect of antipsychotics (APs), which contributes to poor treatment adherence and significant morbidity." | ( Potvin, S; Stip, E; Zhornitsky, S, 2015) |
| "Weight gain is a common but only a partially understood consequence of smoking cessation." | ( Bez, J; Dinter, C; Hermann, D; Hoffmann, H; Kiefer, F; Koopmann, A; Lemenager, T; Reinhard, I; Wiedemann, K; Winterer, G, 2015) |
| "Weight gain is common when stopping smoking." | ( Heggen, E; Klemsdal, TO; Svendsen, M; Tonstad, S, 2016) |
| "Risperidone-related weight gain is associated with a reduction in body iron reserves, which appears to improve with weight loss following risperidone discontinuation." | ( Aman, M; Arnold, LE; Calarge, CA; Del Castillo, N; McCracken, JT; McDougle, CJ; Scahill, L; Ziegler, EE, 2015) |
| "Olanzapine-induced weight gain is associated with atherosclerosis, hypertension, dyslipidemia, and diabetes." | ( Gil-Ad, I; Globus, R; Shbiro, L; Taler, M; Vered, I; Weizman, A; Weller, A, 2016) |
| "Weight gain is a common and serious adverse effect of antipsychotic treatment." | ( Ebdrup, BH; Glenthøj, B; Nielsen, MØ; Rostrup, E; Wulff, S, 2016) |
| "Weight gain is one of the consequences of estrogen deficiency and constitutes a major health problem." | ( Bhattacharya, I; Ghayor, C; Gjoksi, B; Weber, FE; Zenobi-Wong, M, 2016) |
| "Weight gain is an ongoing challenge when initiating insulin therapy in patients with type 2 diabetes mellitus (T2DM)." | ( Almdal, TP; Cichosz, SL; Hejlesen, OK; Johansen, MD; Lundby-Christensen, L; Tarnow, L, 2017) |
| "Weight gain is a possible side effect of the pharmacological antidepressant treatments." | ( Corfitsen, HT; Drago, A, 2017) |
| "Obesity and weight gain are severe complications of mental illness, especially schizophrenia." | ( Grimm, O; Kaiser, S; Plichta, MM; Tobler, PN, 2017) |
| "Weight gain is an important side effect of most atypical antipsychotic drugs such as olanzapine." | ( Lazzari, P; Marcello, S; Mastinu, A; Pira, M; Serra, V, 2017) |
| "Gestational weight gain is one of the factors that could influence the prenatal development, birth weight, and adiposity of newborn." | ( Ducza, E; Gaspar, R; Hajagos-Tóth, J; Samavati, R; Vari, SG, 2017) |
| "Weight gain is a common antipsychotic (AP)-related adverse drug reaction (ADR) that can increase the risk of cardiovascular diseases and premature mortality." | ( Cai, DB; Ng, CH; Ungvari, GS; Wu, RR; Xiang, YT; Yang, XH; Zhang, QE; Zheng, W, 2019) |
| "Weight gain is one of the most challenging issues in patients with schizophrenia treated with antipsychotics." | ( Chen, CH; Goh, KK; Lu, ML, 2019) |
| "This weight gain is related to increases in lean mass and not total, android, or visceral fat." | ( De Jesus, S; Fitzgeorge, L; Prapavessis, H; Rollo, S, 2018) |
| "Weight gain is a potentially concerning side effect of second-generation antipsychotics (SGAs)." | ( Cortese, S; Delorme, R; Ellul, P, 2018) |
| "Weight gain is detrimentally associated with MAD treatment in patients with OSA." | ( Aarab, G; Ahlberg, J; Lobbezoo, F; Tuomilehto, H; Vuorjoki-Ranta, TR, 2019) |
| "Treatment-emergent weight gain is associated with antipsychotic efficacy in schizophrenia patients treated with clozapine and olanzapine." | ( Asmal, L; Chiliza, B; du Plessis, S; Emsley, R; Kilian, S; Luckhoff, H; Phahladira, L; Scheffler, F, 2019) |
| "Weight gain is a common adverse effect of lithium augmentation." | ( Adli, M; Bopp, SK; Bschor, T; Cichon, S; Heilbronner, U; Heinz, A; Hellweg, R; Herms, S; Köhler, S; Lang, UE; Merkl, A; Mühleisen, TW; Richter, C; Ricken, R; Schlattmann, P; Schulze, TG; Stamm, TJ; Steinacher, B; Sterzer, P, 2019) |
| "Excessive weight gain is a potential risk." | ( Alfano, LN; Anand, P; Connolly, AM; Cradock, MM; Finkel, RS; Flanigan, KM; Florence, JM; Golumbek, PT; Iannaccone, ST; Johnson, LB; Kuntz, NL; Lowes, LP; McDonald, CM; Mendell, JR; Nelson, LL; Nicorici, A; Siener, CA; Zaidman, CM, 2019) |
| "Concern about weight gain is a barrier to smoking cessation." | ( Aveyard, P; Bauld, L; Brown, J; Dobbie, F; Jackson, SE; Uny, I; West, R, 2019) |
| "Weight gain is ubiquitous in clinical trials of ART initiation and is multifactorial in nature, with demographic factors, HIV-related factors, and the composition of ART regimens as contributors." | ( Brainard, DM; Brown, TT; Carter, CC; Das, M; Erlandson, KM; Esser, S; Koethe, JR; Lake, JE; Mccomsey, GA; Melbourne, K; Orkin, C; Post, FA; Rockstroh, JK; Sax, PE; Stellbrink, HJ; Waters, L; Wei, X; Zhong, L, 2020) |
| "After discharge, weight gain is almost universal and not associated with any of the perioperative variables." | ( Balachandran, R; Banerji, N; Kotayil, BP; Krishna Kumar, R; Sudhakar, A; Sunil, GS, 2020) |
| "Body weight gain is comparable between the two groups of microbiota-recipient mice." | ( Ambrogi, F; Arnaboldi, F; Bruneau, A; Busnelli, M; Chiesa, G; Colombo, A; Ferrari, B; Gérard, P; Jablaoui, A; Kriaa, A; Maguin, E; Manzini, S; Philippe, C; Rhimi, M, 2020) |
| "Weight gain is common with antiretroviral therapies and can lead to significant medical complications for PWH." | ( Lake, JE; Trevillyan, J, 2021) |
| "Interdialytic weight gain is the change in body weight between two sessions of haemodialysis." | ( Manji, S; Shah, J; Sokwala, A; Twahir, A, 2021) |
| "However, weight gain is a side effect of increasing relevance due to its metabolic implications." | ( Anmella, G; Berk, M; Corponi, F; Fico, G; Giménez-Palomo, A; Gomes-da-Costa, S; Gutiérrez-Arango, F; Kotzalidis, GD; Llach, CD; Marx, W; Murru, A; Pacchiarotti, I; Pons-Cabrera, MT; Valentí, M; Verdolini, N; Vieta, E, 2022) |
| "Weight gain is among the most important side-effects of antipsychotics." | ( Davis, JM; Hamza, T; Leucht, S; Salanti, G; Schneider-Thoma, J; Siafis, S; Wu, H, 2022) |
| "Weight gain is a hallmark of decreased estradiol (E2) levels because of menopause or following surgical ovariectomy (OVX) at younger ages." | ( Al-Massadi, O; Beiroa, D; Blouet, C; Diéguez, C; Heras, V; López, M; Nogueiras, R; Novelle, MG; Romero-Picó, A; Ruiz-Pino, F; Senra, A; Tena-Sempere, M; Tojo, M, 2022) |
| "Although weight gain is expected in pregnancy, excessive weight gain may exacerbate IIH and increase maternal and fetal complications; evidence-based recommendations for non-IIH pregnancies may help in guiding optimal gestational weight gain." | ( Abbott, S; Mollan, SP; Sinclair, AJ; Tahrani, AA; Thaller, M; Wakerley, BR, 2022) |
| "Although weight gain is recognized as a side effect of DTG, it may be welcomed by some WLHIV." | ( Alhassan, Y; Colbers, A; Khoo, S; Lamorde, M; Malaba, T; Myer, L; Reynolds, H; Taegtmeyer, M; Twimukye, A; Waitt, C, 2022) |
| "It is possible that weight gain is mainly driven by APs." | ( Bartels-Velthuis, AA; Bruggeman, R; Burin, LM; Cahn, W; da Rocha, NS; de Haan, L; Hahn, MK; Schirmbeck, F; Simons, CJP; van Amelsvoort, T; van Os, J, 2022) |
| "Weight gain is the one of the most important factors which increases global burden of psychiatric disorder." | ( Altunkaynak, Z; Bilgici, B; Gümrükçüoğlu, Tİ; Karaustaoğlu, A; Tunçel, ÖK, 2022) |
| "Drug-induced weight gain is a profound side effect of numerous commonly used medications." | ( Ahmed, NJ; Alahmari, A; Almalki, ZS; Alshehri, AM, 2022) |
| "Weight gain is commonly observed during and after breast cancer treatment and is associated with poorer survival outcomes, notably in women with oestrogen-receptor positive disease." | ( As, A; C, W; H, C; J, C; J, G; J, H; Jm, S; K, P; Rj, C; Rjq, M; S, W, 2022) |
| "Weight gain is commonly observed during and after breast cancer treatment and is associated with poorer survival outcomes, notably in women with oestrogen-receptor positive disease." | ( As, A; C, W; H, C; J, C; J, G; J, H; Jm, S; K, P; Rj, C; Rjq, M; S, W, 2022) |
| "Weight gain is commonly observed during and after breast cancer treatment and is associated with poorer survival outcomes, notably in women with oestrogen-receptor positive disease." | ( As, A; C, W; H, C; J, C; J, G; J, H; Jm, S; K, P; Rj, C; Rjq, M; S, W, 2022) |
| "Weight gain is a frequent side effect of treatment with SGAs (second-generation antipsychotics) and a leading cause for nonadherence." | ( Heres, S; Leucht, S; Schreyer, KF; Steimer, W, 2023) |
| "Although this weight gain is a multifactorial process in which lifestyle habits, physical exercise or diet have a great impact, antiretroviral treatment has been recently considered as one of the key causes of this increase according to different clinical trials and real-life cohorts." | ( Galindo, MJ; González, CS; Lillo, IS; Rodríguez, AP, 2023) |
| "Weight gain is an unexplored side effect reported in approximately 10%." | ( de Leeuw, SP; Dingemans, AC; Dumoulin, DW; Mathijssen, RHJ; Mohseni, M; Paats, MS; Pruis, MA; Schols, AMWJ; Sikkema, BJ; Smit, EF; van Rossum, EFC; Veerman, GDM, 2023) |
| "Weight gain is a known adverse effect of ruxolitinib, a JAK1/2 inhibitor that is the mainstay of treatment for many patients with myelofibrosis." | ( Dougherty, M; Gallagher, EJ; Mascarenhas, J; Tremblay, D, 2023) |
| "The fear of weight gain is one of the main reasons for women not to initiate or to early discontinue hormonal contraception or menopausal hormone therapy." | ( Janka, H; Pape, J; Stute, P; von Wolff, M; Weidlinger, M; Weidlinger, S; Winterberger, K, 2023) |
| "Rapid infant weight gain is predictive of childhood overweight." | ( Alterman, N; Broday, D; Calderon-Margalit, R; Hauzer, M; Nevo, D; Raz, R; Youssim, I, 2023) |
| "Adult weight gain is an independent indicator of breast cancer risk." | ( Berry, WL; Borchers, CH; Castillo-Castrejon, M; Cen, HH; Johnson, JD; Jones, KL; Murguia, SJ; Richard, VR; Sankofi, BM; Thomas, NS; Udeme, AA; Wellberg, EA; Xia, YH; Zahedi, RP, 2023) |